Skip to content

Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting

Loss of Independence (LOI) - a Rapid Alternative to Frailty Screening in a Swedish Emergency Department Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04888884
Enrollment
1800
Registered
2021-05-17
Start date
2021-09-27
Completion date
2021-12-31
Last updated
2022-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Department, Frailty, Frailty Syndrome, Geriatric Assessment

Brief summary

This prospective observational study will investigate the correlation of a surrogate marker of frailty in relation to serious outcomes. Serious outcomes are defined as: mortality within 30 days, admission to hospital, length of stay in the Emergency Department (ED), in-hospital Length of Stay and revisits to the ED. The exposure, frailty, will be assessed according to Loss of Independence (LOI) a possible low-cost quick tool to identify frailty in patients. The study population will be ED patients, \>65 years of age in a Swedish regional health care system (Region Östergötland, Sweden), comprising three EDs in Linköping, Norrköping and Motala. The outcomes will be compared according to the degree of frailty and censored over 7, 30 and 90 days.

Detailed description

Frailty is a common clinical syndrome in older adults that carries an increased risk for poor health outcomes including falls, incident disability, hospitalization and mortality. The Loss of Independence (LOI) defined as inability to rise from a chair with or without existing aids, is a possible low cost surrogate marker to measure frailty. Several studies on triage scores for predicting mortality and need of hospital admission have identified LOI as one of the most important variables. LOI was prognostic in ED populations regarding mortality within 1-30 days in Denmark, Ireland and Tanzania. Data from the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) Geriatric Surgery Pilot Project showed that LOI was associated with higher rates of readmission and death after discharge in geriatric patients undergoing surgical procedures6. The aim of this study will be to investigate if the frailty, as assessed with LOI, is associated with increased 30-day mortality in a Swedish ED context. Secondary outcomes include 7- and 90-day mortality, ED-length of stay, hospital admission, in-hospital length of stay, subsequent falls and medication changes. Additionally, we collect data on morbidity and comorbidities to assess the association with the level of frailty. Since this is a multicentre study, possible geographic differences will be studied as well. Based on the results of this study, possible interventions could be identified to improve the care of the frail geriatric patients presenting at the ED.

Interventions

None listed

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 65 years * able to answer questions to estimate frailty * or have a proxy to answer questions

Exclusion criteria

* \<65 years * unable to answer questions to estimate frailty

Design outcomes

Primary

MeasureTime frameDescription
Mortality in 30 DaysAll cause mortality up to 30 days from index visitInvestigate level of mortality in cohort at 30 days

Secondary

MeasureTime frameDescription
Admission to hospitalHospital admission on index visit, censored at 90 daysInvestigate level of all cause admissions in cohort
ED length of stayLength of stay at ED, censored at 4 daysInvestigate length of stay at ED
In-hospital length of stayIn-hospital length of stay from index visit, censored at 90 daysInvestigate in-hospital length of stay
Mortality in 7 and 90 daysAll cause mortality up to 90 days from index visitInvestigate level of mortality in cohort at 7 and 90 days
Fall prevalence after index visitFalls that resulted in further health care contacts after index visit, censored at 90 daysFalls that resulted in further health care contacts
Alterations in medication during the visitAlterations in medication during the ED visit and during the follow-up period, censored at 90 daysAlterations in medication during the ED visit and during the follow-up period(based on codes for Anatomical, Therapeutic, Chemical classification (ATC-code)
Revisits to the EDNumber of newly registered visits to the ED after index visit, censored at 90 daysNumber of newly registered visits to the ED after index visit

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026